Bayesian decision theoretic two-stage design in Phase II clinical trials with survival endpoint

nork Zhao, Lili, Taylor, Jeremy M.G., Schuetze, Scott M
Argitaratua 2012

Alveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 Therapy

nork Zyczynski, Laura E., McHugh, Jonathan B., Gribbin, Thomas E., Schuetze, Scott M.
Argitaratua izan da Case Rep Oncol Med (2015)

[F-18]-fluorodeoxy-D-glucose Positron Emission Tomography Response is Associated with Outcome for Extremity Osteosarcoma in Children and Young Adults

nork Hawkins, Douglas S., Conrad, Ernest U., Butrynski, James E., Schuetze, Scott M., Eary, Janet F.
Argitaratua 2009

The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975–2004)

nork Beebe-Dimmer, Jennifer L, Cetin, Karynsa, Fryzek, Jon P, Schuetze, Scott M, Schwartz, Kendra
Argitaratua 2009

Sarcoma Mid-Therapy [F-18]Fluorodeoxyglucose Positron Emission Tomography (FDG PET) and Patient Outcome

nork Eary, Janet F., Conrad, Ernest U., O’Sullivan, Janet, Hawkins, Douglas S., Schuetze, Scott M., O’Sullivan, Finbarr
Argitaratua 2014

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

nork Davis, Elizabeth J., Zhao, Lili, Lucas, David R., Schuetze, Scott M., Baker, Laurence H., Zalupski, Mark M., Thomas, Dafydd, Chugh, Rashmi
Argitaratua izan da BMC Cancer (2016)

Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases

nork Siontis, Brittany L., Zhao, Lili, Leja, Monika, McHugh, Jonathan B., Shango, Maryann M., Baker, Laurence H., Schuetze, Scott M., Chugh, Rashmi
Argitaratua izan da Sarcoma (2019)

Next generation sequencing of extraskeletal myxoid chondrosarcoma

nork Davis, Elizabeth J., Wu, Yi-Mi, Robinson, Dan, Schuetze, Scott M., Baker, Laurence H., Athanikar, Jyoti, Cao, Xuhong, Kunju, Lakshmi P., Chinnaiyan, Arul M., Chugh, Rashmi
Argitaratua izan da Oncotarget (2017)

Differential Outcomes and Biologic Markers of Radiation-Associated vs. Sporadic Osteosarcoma: A Single-Institution Experience

nork Siontis, Brittany L., McHugh, Jonathan B., Roberts, Emily, Zhao, Lily, Thomas, Dafydd G., Owen, Dawn, Baker, Laurence H., Biermann, J. Sybil, Schuetze, Scott M., Chugh, Rashmi
Argitaratua izan da Front Oncol (2020)

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival

nork Koshkin, Vadim S., Bolejack, Vanessa, Schwartz, Lawrence H., Wahl, Richard L., Chugh, Rashmi, Reinke, Denise K., Zhao, Binsheng, O, Joo H., Patel, Shreyaskumar R., Schuetze, Scott M., Baker, Laurence H.
Argitaratua izan da J Clin Oncol (2016)

Response to Early Treatment Evaluated with (18)F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the...

nork Hyun O, Joo, Luber, Brandon S., Leal, Jeffrey P., Wang, Hao, Bolejack, Vanessa, Schuetze, Scott M., Schwartz, Lawrence H., Helman, Lee J., Reinke, Denise, Baker, Laurence H., Wahl, Richard L.
Argitaratua izan da J Nucl Med (2016)

Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

nork Rutkowski, Piotr, Van Glabbeke, Martine, Rankin, Cathryn J., Ruka, Wlodzimierz, Rubin, Brian P., Debiec-Rychter, Maria, Lazar, Alexander, Gelderblom, Hans, Sciot, Raf, Lopez-Terrada, Dolores, Hohenberger, Peter, van Oosterom, Allan T., Schuetze, Scott M.
Argitaratua 2010

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing’s sarcoma: a phase 1 expansion cohort stu...

nork Olmos, David, Postel-Vinay, Sophie, Molife, L Rhoda, Okuno, Scott H, Schuetze, Scott M, Paccagnella, M Luisa, Batzel, Gretchen N, Yin, Donghua, Pritchard-Jones, Kathryn, Judson, Ian, Worden, Francis P, Gualberto, Antonio, Scurr, Michelle, de Bono, Johann S, Haluska, Paul
Argitaratua 2009

Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer

nork Jones, Robin L., Herzog, Thomas J., Patel, Shreyaskumar R., von Mehren, Margaret, Schuetze, Scott M., Van Tine, Brian A., Coleman, Robert L., Knoblauch, Roland, Triantos, Spyros, Hu, Peter, Shalaby, Waleed, McGowan, Tracy, Monk, Bradley J., Demetri, George D.
Argitaratua izan da Cancer Med (2021)

Linsitinib (OSI-906) for the treatment of Adult and Pediatric Wild Type Gastrointestinal Stromal Tumors, a SARC Phase II study

nork von Mehren, Margaret, George, Suzanne, Heinrich, Michael C., Schuetze, Scott M., Yap, Jeffrey T., Yu, Jain Q., Abbott, Amanda, Litwin, Samuel, Crowley, John, Belinsky, Martin G., Janeway, Katherine A., Hornick, Jason L., Flieder, Douglas B., Chugh, Rashmi, Rink, Lori A., Van den Abbeele, Annick A.
Argitaratua izan da Clin Cancer Res (2019)

Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)

nork Kasper, Bernd, Achee, Annie, Schuster, Kathrin, Wilson, Roger, van Oortmerssen, Gerard, Gladdy, Rebecca A., Hemming, Matthew L., Huang, Paul, Ingham, Matthew, Jones, Robin L., Pollack, Seth M., Reinke, Denise, Sanfilippo, Roberta, Schuetze, Scott M., Somaiah, Neeta, Van Tine, Brian A., Wilky, Breelyn, Okuno, Scott, Trent, Jonathan
Argitaratua izan da Cancers (Basel) (2021)

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Al...

nork Pappo, Alberto S., Patel, Shreyaskumar R., Crowley, John, Reinke, Denise K., Kuenkele, Klaus-Peter, Chawla, Sant P., Toner, Guy C., Maki, Robert G., Meyers, Paul A., Chugh, Rashmi, Ganjoo, Kristen N., Schuetze, Scott M., Juergens, Heribert, Leahy, Michael G., Geoerger, Birgit, Benjamin, Robert S., Helman, Lee J., Baker, Laurence H.
Argitaratua 2011

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multice...

nork Demetri, George D., von Mehren, Margaret, Jones, Robin L., Hensley, Martee L., Schuetze, Scott M., Staddon, Arthur, Milhem, Mohammed, Elias, Anthony, Ganjoo, Kristen, Tawbi, Hussein, Van Tine, Brian A., Spira, Alexander, Dean, Andrew, Khokhar, Nushmia Z., Park, Youn Choi, Knoblauch, Roland E., Parekh, Trilok V., Maki, Robert G., Patel, Shreyaskumar R.
Argitaratua izan da J Clin Oncol (2016)

Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib

nork Schuetze, Scott M., Bolejack, Vanessa, Thomas, Dafydd G., von Mehren, Margaret, Patel, Shreyaskumar, Samuels, Brian, Choy, Edwin, D’Amato, Gina, Staddon, Arthur P., Ganjoo, Kristen N., Chow, Warren A., Rushing, Daniel A., Forscher, Charles A., Priebat, Dennis A., Loeb, David M., Chugh, Rashmi, Okuno, Scott, Reinke, Denise K., Baker, Laurence H.
Argitaratua izan da JAMA Oncol (2018)

SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors

nork Higham, Christine S., Steinberg, Seth M., Dombi, Eva, Perry, Arie, Helman, Lee J., Schuetze, Scott M., Ludwig, Joseph A., Staddon, Arthur, Milhem, Mohammed M., Rushing, Daniel, Jones, Robin L., Livingston, Michael, Goldman, Stewart, Moertel, Christopher, Wagner, Lars, Janhofer, David, Annunziata, Christina M., Reinke, Denise, Long, Lauren, Viskochil, David, Baker, Larry, Widemann, Brigitte C.
Argitaratua izan da Sarcoma (2017)